| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-08 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |